Login to Your Account

Other News To Note

Friday, February 18, 2011
Barroway Topaz Kessler Meltzer & Check LLP, of Radnor, Pa., filed a shareholder class action lawsuit in the U.S. District Court for the Central District of California against MannKind Corp., of Valencia, Calif. Included among the allegations are that MannKind failed to disclose that inhaled insulin candidate Afrezza was riskier than the company had portrayed and that it was unlikely the FDA would approve Afrezza in the near future.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription